264 related articles for article (PubMed ID: 30925542)
21. Early Metabolic Response to Neoadjuvant Treatment: FDG PET/CT Criteria according to Breast Cancer Subtype.
Groheux D; Majdoub M; Sanna A; de Cremoux P; Hindié E; Giacchetti S; Martineau A; de Roquancourt A; Merlet P; Visvikis D; Resche-Rigon M; Hatt M; Espié M
Radiology; 2015 Nov; 277(2):358-71. PubMed ID: 25915099
[TBL] [Abstract][Full Text] [Related]
22. Association between partial-volume corrected SUVmax and Oncotype DX recurrence score in early-stage, ER-positive/HER2-negative invasive breast cancer.
Lee SH; Ha S; An HJ; Lee JS; Han W; Im SA; Ryu HS; Kim WH; Chang JM; Cho N; Moon WK; Cheon GJ
Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1574-84. PubMed ID: 27209424
[TBL] [Abstract][Full Text] [Related]
23. Comparison of standardized uptake value of 18F-FDG-PET-CT with 21-gene recurrence score in estrogen receptor-positive, HER2-negative breast cancer.
Ahn SG; Lee JH; Lee HW; Jeon TJ; Ryu YH; Kim KM; Sohn J; Yun M; Lee SA; Jeong J; Kim SI
PLoS One; 2017; 12(4):e0175048. PubMed ID: 28419166
[TBL] [Abstract][Full Text] [Related]
24. 18F-FDG retention index and biologic prognostic parameters in breast cancer.
García Vicente AM; Castrejón ÁS; Relea Calatayud F; Muñoz AP; León Martín AA; López-Muñiz IC; Del Mar Muñoz Sánchez M; Cordero García JM; Becerra Nakayo EM
Clin Nucl Med; 2012 May; 37(5):460-6. PubMed ID: 22475895
[TBL] [Abstract][Full Text] [Related]
25. The clinical significance of standardized uptake value in breast cancer measured using 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
Kim YH; Lee JA; Baek JM; Sung GY; Lee DS; Won JM
Nucl Med Commun; 2015 Aug; 36(8):790-4. PubMed ID: 25932535
[TBL] [Abstract][Full Text] [Related]
26. Textural features and SUV-based variables assessed by dual time point 18F-FDG PET/CT in locally advanced breast cancer.
Garcia-Vicente AM; Molina D; Pérez-Beteta J; Amo-Salas M; Martínez-González A; Bueno G; Tello-Galán MJ; Soriano-Castrejón Á
Ann Nucl Med; 2017 Dec; 31(10):726-735. PubMed ID: 28887761
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Value of Percentage Change in Metabolic Parameters as Measured by Dual-Time Point
Yoo J; Yoon HJ; Kim BS
J Womens Health (Larchmt); 2017 Oct; 26(10):1131-1137. PubMed ID: 28498790
[TBL] [Abstract][Full Text] [Related]
28. 18F-fluorodeoxyglucose PET/computed tomography in locoregional staging and assessment of biological and clinical aggressiveness of breast cancer subtypes.
Ozkan EE; Sengul SS; Erdogan M; Gurdal O; Eroglu HE
Nucl Med Commun; 2019 Oct; 40(10):1043-1050. PubMed ID: 31425343
[TBL] [Abstract][Full Text] [Related]
29. Diffusion-weighted imaging and FDG PET/CT: predicting the prognoses with apparent diffusion coefficient values and maximum standardized uptake values in patients with invasive ductal carcinoma.
Choi BB; Kim SH; Kang BJ; Lee JH; Song BJ; Jeong SH; Yim HW
World J Surg Oncol; 2012 Jun; 10():126. PubMed ID: 22741544
[TBL] [Abstract][Full Text] [Related]
30. Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer.
Groheux D; Giacchetti S; Moretti JL; Porcher R; Espié M; Lehmann-Che J; de Roquancourt A; Hamy AS; Cuvier C; Vercellino L; Hindié E
Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):426-35. PubMed ID: 21057787
[TBL] [Abstract][Full Text] [Related]
31. Correlation of the SUVmax of FDG-PET and ADC values of diffusion-weighted MR imaging with pathologic prognostic factors in breast carcinoma.
Kitajima K; Yamano T; Fukushima K; Miyoshi Y; Hirota S; Kawanaka Y; Miya M; Doi H; Yamakado K; Hirota S
Eur J Radiol; 2016 May; 85(5):943-9. PubMed ID: 27130054
[TBL] [Abstract][Full Text] [Related]
32. Utility of
Ravina M; Saboury B; Chauhan MS; Jacob MJ; Pandit AG; Sanchety N; Werner TJ; Alavi A
Hell J Nucl Med; 2019; 22(3):165-171. PubMed ID: 31587025
[TBL] [Abstract][Full Text] [Related]
33. Prediction of Recurrence and Mortality of Locally Advanced Esophageal Cancer Patients Using Pretreatment F-18 FDG PET/CT Parameters: Intratumoral Heterogeneity, SUV, and Volumetric Parameters.
Chang S; Kim SJ
Cancer Biother Radiopharm; 2016 Feb; 31(1):1-6. PubMed ID: 26844846
[TBL] [Abstract][Full Text] [Related]
34. Volume-based parameters of 18F-fluorodeoxyglucose positron emission tomography/computed tomography improve disease recurrence prediction in postmastectomy breast cancer patients with 1 to 3 positive axillary lymph nodes.
Nakajima N; Kataoka M; Sugawara Y; Ochi T; Kiyoto S; Ohsumi S; Mochizuki T
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):738-46. PubMed ID: 24064322
[TBL] [Abstract][Full Text] [Related]
35. Prediction of breast cancer recurrence using lymph node metabolic and volumetric parameters from
Kim YI; Kim YJ; Paeng JC; Cheon GJ; Lee DS; Chung JK; Kang KW
Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1787-1795. PubMed ID: 28616695
[TBL] [Abstract][Full Text] [Related]
36.
Ulaner GA; Castillo R; Wills J; Gönen M; Goldman DA
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(9):1420-1427. PubMed ID: 28456837
[TBL] [Abstract][Full Text] [Related]
37. Reliability of
Jena A; Taneja S; Singh A; Negi P; Sarin R; Das PK; Singhal M
AJR Am J Roentgenol; 2017 Sep; 209(3):662-670. PubMed ID: 28678576
[TBL] [Abstract][Full Text] [Related]
38. Correlation analysis of 18F-FDG PET/CT for the staging and treatment effect assessment of breast cancer.
Li Y; Dai Y; Guo Y; Wang J; Duan X
J Xray Sci Technol; 2019; 27(6):1131-1144. PubMed ID: 31561405
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of FDG-PET and DWI in breast cancer.
Kitajima K; Miyoshi Y; Yamano T; Odawara S; Higuchi T; Yamakado K
Ann Nucl Med; 2018 Jan; 32(1):44-53. PubMed ID: 29134565
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic value of
Nguyen A; Fullard K; Sheehan-Dare G; Tang R; Chan L; Ho B; Dear R; Keane J; Hickey A; Nandurkar R; Chen J; Chen A; Lim E; Emmett L
J Med Imaging Radiat Oncol; 2022 Sep; 66(6):731-737. PubMed ID: 34676675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
